News
National Vision (EYE) holds a Zacks Rank of #2 (Buy), reflecting strong earnings estimate revisions, while Hermes International SA – Unsponsored ADR (HESAY) carries a #4 (Sell) ranking. EYE’s forward price‑to‑earnings ratio is 30.39, notably lower than HESAY’s 45.24, indicating a less expensive valuation relative to expected earnings. The PEG ratio...
24/02/2026 | National Vision Holdings, Inc.
Looking ahead, Tandem forecasts modest but profitable growth for 2026, projecting full‑year sales between $1.065 billion and $1.085 billion and gross margins of 56% to 57%. The company attributes its improving financials to a new pay‑as‑you‑go pharmacy model in the United States, which is shifting its revenue stream toward more predictable and high...
23/02/2026 | Tandem Diabetes Care, Inc.
Tandem Diabetes Care’s shares rose over 32% after the company released its fourth‑quarter earnings, which showed a 3% year‑over‑year revenue increase to $290 million. Worldwide insulin‑pump shipments reached 38,000 units, including 27,000 in the United States, reflecting the continued demand for its devices.
23/02/2026 | Tandem Diabetes Care, Inc.
The company’s fundamentals remain solid, with a 4 % dividend yield and expected revenue growth of 1.78 % next year. Investor sentiment is positive, with 439 Motley Fool followers and 15,600 Seeking Alpha users rating HST “Strong Buy.” Short interest is low at 4.20 % of the float, 3.06 days to cover.
23/02/2026 | Host Hotels & Resorts, Inc.
Host Hotels & Resorts (HST) has reached a new 52‑week high, with shares up 20.64 % over the past year. The stock has recorded 10 new highs and displays strong technical momentum, shown by a 100 % “Buy” rating from Barchart, a Weighted Alpha of +32.21, and a Trend Seeker “Buy” signal. The RSI sits at 65.77, indicating support near $19.65. Analysts a...
23/02/2026 | Host Hotels & Resorts, Inc.
Fusion Fuel Green PLC (NASDAQ: HTOO) has signed a definitive agreement to acquire a controlling interest in Royal Uranium Inc., which holds a diversified portfolio of nineteen uranium and natural‑gas royalties. The portfolio includes sixteen uranium royalties and three natural‑gas royalties operated by industry leaders such as Cameco and IsoEnergy....
19/02/2026 | Fusion Fuel Green PLC
In healthcare and longevity, capAI’s subsidiary capMedical Inc. is evaluating AI‑enabled preventative health initiatives through a capital‑light operating model. The firm employs a lean “tiny teams” framework to maximize operating leverage, reduce fixed overhead, and accelerate platform development, thereby aligning disciplined capital allocation w...
19/02/2026 | capAI Plc
capAI PLC announced its participation in the AI & Technology Virtual Investor Conference, highlighting a series of strategic initiatives designed to accelerate growth across multiple sectors. The company has entered a partnership with R42 Group, a venture fund and institute aligned with capAI’s objectives, structured around exclusive licensing and...
19/02/2026 | capAI Plc
Chesnara PLC announced it will acquire Scottish Widows Europe from Lloyds Banking Group for €110 million in cash. The transaction will add €1.7 billion of assets to Chesnara’s balance sheet and is expected to generate €250 million of lifetime cash. The deal represents a major expansion for Chesnara, positioning the company for long‑term growth. Ana...
19/02/2026 | Chesnara plc
Shares have fallen 16.9 % over the past six months, underperforming the industry’s 8.6 % growth, yet the company’s fiscal 2027 consensus EPS estimate remains at $4.58, unchanged over the past 30 days. Consensus revenue for the fourth quarter of fiscal 2026 is pegged at $332.9 million, implying a 6.7 % year‑over‑year increase. HealthEquity identifie...
19/02/2026 | HealthEquity, Inc.